Herpesviruses have been isolated from a wide range of hosts including humans-for which, nine species have been designated. The human herpesviruses are highly host adapted and possess the capacity for latency, allowing them to survive in the host for life, effectively hidden from the immune system. This ability of human herpesviruses to modulate the...
Misfolded alpha-synuclein proteins in the brain are the hallmark sign of Parkinson's disease.
Stroke and sleep apnea are highly prevalent conditions with a physiologically plausible bidirectional relationship.
Visual snow is considered a disorder of central visual processing resulting in a perturbed perception of constant bilateral whole-visual field flickering or pixelation. When associated with additional visual symptoms, it is referred to as visual snow syndrome. Its pathophysiology remains elusive.
To help determine whether midlife obesity is a cause of dementia and whether low body mass index (BMI), low caloric intake, and physical inactivity are causes or merely consequences of the gradual onset of dementia by recording these factors early in a large 20-year prospective study and relating them to dementia detection rates separately during...
Second language learning induces grey matter volume increase in people with multiple sclerosis.
A recent study shows that healthy sleep patterns were associated with a reduced risk of heart disease and stroke by about one-third, even among those at high genetic risk.
Ubrogepant is the first drug in the calcitonin-related peptide receptor antagonist class approved for the acute treatment of migraine.
In the study published by Suzanne M. Bertisch et al. and entitled Nighttime Sleep Duration, Fragmentation and Daily Sleep Quality and Risk of Migraine, they attempt to test the hypotheses that insufficient duration, high fragmentation and poor sleep quality are temporarily associated with the onset of migraine on the day immediately following the...
The time to initiate intravenous thrombolysis for acute ischemic stroke is generally limited to within 4.5 hours after the onset of symptoms. Some trials have suggested that the treatment window may be extended in patients who are shown to have ischemic but not yet infarcted brain tissue on imaging.
